Spectrum Science Acquires Return on Focus
September 30, 2025
Spectrum Science has acquired Return on Focus, a strategic marketing consultancy that provides evidence-based brand positioning and strategic services to pharmaceutical and biotech companies. The acquisition strengthens Spectrum’s strategic and commercial capabilities—bringing Return on Focus’ data-driven positioning expertise into Spectrum’s integrated healthcare marketing platform; Dan Reinhardt and Abby Manning will continue to lead the ROF team.
- Buyers
- Spectrum Science
- Targets
- Return on Focus
- Platforms
- Spectrum Science
- Industry
- Marketing & Advertising
- Location
- New Jersey, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Ness Digital Engineering Acquires Risk Focus
May 14, 2021
IT Services
Ness, a digital engineering firm and portfolio company of The Rohatyn Group, has agreed to acquire Risk Focus, a New York–headquartered consulting firm specializing in digital transformation for financial services. The acquisition is an add-on to Ness's industry cloud and data capabilities, intended to deepen its cloud, data and AI advisory and delivery for financial services clients; financial terms were not disclosed.
-
Lennox Acquires Focus Scientific Solutions
February 1, 2022
Medical Devices
Lennox Holdings Ltd has acquired Focus Scientific Solutions, a Meath-based supplier of laboratory equipment and technical services, making Lennox the largest independent Irish company in the sector. The acquisition expands Lennox’s technical services capability and product portfolio to better serve biopharma and life sciences customers.
-
Spectrum Science Acquires SONIC Health
June 7, 2022
Marketing & Advertising
Spectrum Science, an independent health- and science-focused marketing and communications agency, acquired SONIC Health, a strategic storytelling agency founded by Fabio Gratton and Ross Fetterolf. The SONIC team will join Spectrum as the SONIC Story Lab to expand Spectrum’s creative storytelling and content capabilities; financing for the acquisition was provided by Monroe Capital.
-
Full-Life Technologies Acquires Focus‑X Therapeutics
November 28, 2022
Biotechnology
Full‑Life Technologies, a global radiotherapeutics company, agreed to acquire New Jersey‑based Focus‑X Therapeutics to expand its peptide‑focused radiopharmaceutical pipeline. Focus‑X shareholders are eligible for an upfront payment plus up to $245 million in development, regulatory and sales milestones and royalties; the deal was expected to close in Q1 2023.
-
Spectrum Science Acquires Continuum Clinical
February 8, 2024
Healthcare Services
Spectrum Science has acquired Continuum Clinical from Blue Chip Worldwide to strengthen its clinical trial recruitment (CTR) capabilities. Continuum will merge into Spectrum’s CTR strategic pillar—bringing its MERIS technology, a large client roster, and leadership under Neil Weisman—creating a combined team of more than 130 clinical solutions specialists; financial terms were not disclosed.
-
Focus Group (Bowmark-backed) Acquires &Partners, Boxx Communications and RPM Communications
January 16, 2024
IT Services
Bowmark-backed Focus Group completed three add-on acquisitions—&Partners, Boxx Communications and RPM Communications—during the last six months to broaden its cloud, cybersecurity and communications capabilities and expand its UK footprint. The deals strengthen Focus Group’s specialist healthcare communications capability (RPM) and enhance cloud and Microsoft/cybersecurity services (&Partners), while extending regional connectivity and unified-communications coverage (Boxx).
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.